Follow
Krisztina Matúz
Krisztina Matúz
Verified email at med.unideb.hu - Homepage
Title
Cited by
Cited by
Year
Interactions of retinoids with the ABC transporters P-glycoprotein and Breast Cancer Resistance Protein
S Tarapcsák, G Szalóki, Á Telbisz, Z Gyöngy, K Matúz, É Csősz, P Nagy, ...
Scientific reports 7 (1), 41376, 2017
312017
Bovine leukemia virus protease: comparison with human T-lymphotropic virus and human immunodeficiency virus proteases
T Sperka, G Miklossy, Y Tie, P Bagossi, G Zahuczky, P Boross, K Matuz, ...
Journal of general virology 88 (7), 2052-2063, 2007
292007
Inhibition of XMRV and HIV‐1 proteases by pepstatin A and acetyl‐pepstatin
K Matúz, J Mótyán, M Li, A Wlodawer, J Tőzsér
The FEBS journal 279 (17), 3276-3286, 2012
212012
C-terminal residues of mature human T-lymphotropic virus type 1 protease are critical for dimerization and catalytic activity
J Kádas, P Boross, IT Weber, P Bagossi, K Matúz, J Tözsér
Biochemical Journal 416 (3), 357-364, 2008
182008
Structural and biochemical characterization of the inhibitor complexes of xenotropic murine leukemia virus‐related virus protease
M Li, A Gustchina, K Matúz, J Tözsér, S Namwong, NE Goldfarb, BM Dunn, ...
The FEBS journal 278 (22), 4413-4424, 2011
162011
Enhanced stability of monomer fold correlates with extreme drug resistance of HIV-1 protease
JM Louis, J Tözsér, J Roche, K Matúz, A Aniana, JM Sayer
Biochemistry 52 (43), 7678-7688, 2013
142013
Biochemical characterization, specificity and inhibition studies of HTLV-1, HTLV-2, and HTLV-3 proteases
N Kassay, JA Mótyán, K Matúz, M Golda, J Tőzsér
Life 11 (2), 127, 2021
112021
A modular system to evaluate the efficacy of protease inhibitors against HIV-2
M Mahdi, K Matúz, F Tóth, J Tőzsér
PLoS One 9 (11), e113221, 2014
112014
Biochemical characterization of human retroviral-like aspartic protease 1 (ASPRV1)
M Golda, JA Mótyán, K Nagy, K Matúz, T Nagy, J Tőzsér
Biomolecules 10 (7), 1004, 2020
82020
Goldfarb, NE, Dunn,. B. N. and Wlodawer, A.(2011). Structural and biochemical characterization of the inhibitor complexes of xenotropic murine leukemia virus-related virus protease
M Li, A Gustchina, K Matúz, J Tözsér, S Namwong
FEBS Lett 278 (22), 4413-24, 0
4
Different mutation tolerance of Lentiviral (HIV-1) and deltaretroviral (BLV and HTLV) protease precursors
JA Mótyán, N Kassay, K Matúz, J Tőzsér
Viruses 14 (9), 1888, 2022
22022
Bovine Leukemia Virus Retropepsin
T Sperka, K Matúz, J Tözsér
Handbook of Proteolytic Enzymes, 218-220, 2013
12013
A Xenotróp Egér Leukémia Vírussal Rokon Vírus (XMRV) Proteáz Biokémiai Karakterizálása
K Matúz
PQDT-Global, 2013
2013
A retrovirális proteázok szerepének vizsgálata a retrovírusok életciklusának korai fázisában= Studies on the retroviral protease in the early phase of life-cycle
J Tőzsér, P Bagossi, P Bander, P Boross, H Eizert, K Matúz, G Miklóssy, ...
OTKA Kutatási Jelentések| OTKA Research Reports, 2012
2012
Interactions of retinoids with the ABC transporters P-glycoprotein and Breast Cancer Resistance Protein Running title: Interactions of retinoids with ABCB1 and ABCG2
S Tarapcsák, G Szalóki, Á Telbisz, Z Gyöngy, K Matúz, É Csősz, P Nagy, ...
The system can't perform the operation now. Try again later.
Articles 1–15